Bladder cancer trials in Romania

4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 4Taking people
  A Rollover Study to Follow the Long-term Durability of Response to UGN-103 in Participants With Recurrent Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer (LG-IR-NMIBC) From Study BL013

  Where

  Brasov, Bucharest

  Age

  18 years and over

  People

  33 worldwide

  Run by

  Urogen Pharma Ltd.

  See details and how to join2026-526359-75-00 · EU 2026-526359-75-00
• Phase 3Taking people
  Roll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab

  Where

  Suceava

  Age

  18 years and over

  People

  87 worldwide

  Run by

  Astrazeneca AB

  See details and how to joinNCT05303532 · EU 2023-507337-22-00
• Phase 3Taking people
  A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

  Where

  Bucharest, Cluj-Napoca, Iași, Oradea, Timișoara

  Age

  18 years and over

  People

  70 worldwide

  Run by

  UroGen Pharma Ltd.

  See details and how to joinNCT06774131 · EU 2024-519343-15-00
• Phase 2/3Taking people
  Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

  Where

  Cluj-Napoca, Craiova, Iași

  Age

  18 years and over

  People

  470 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT07106762